Pinho Mario 4

What Happened Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), received a grant of 153,125 restricted stock units (RSUs) on April 15, 2026. The filing records the award as a derivative grant (transaction code A) with an acquisition price of $0.00. The RSUs were issued in lieu of a portion of the reporting person’s annual bonus for the fiscal year ended December 31, 2025.

Key Details

• Transaction date and filing: Grant dated 2026-04-15; Form 4 filed 2026-04-17 (appears timely).
• Security and amount: 153,125 RSUs granted; reported as a derivative award at $0.00.
• Conversion/vesting: RSUs convert one-for-one to common stock (F1). Vesting in four equal installments on 07/15/2026, 10/15/2026, 01/15/2027 and 04/15/2027 (F2).
• Shares owned after transaction: Not disclosed in the provided summary of the filing.
• Purpose note: Grant was made in lieu of cash payment of a portion of the CFO’s 2025 annual bonus (Remarks).

Context RSU grants are compensation awards, not open-market purchases or sales, so they do not directly signal buy/sell decisions by the insider. Upon vesting the RSUs will convert to common shares on a one-for-one basis, at which point any sale or withholding for taxes would be reported separately on subsequent filings.